Improved CRISPR-Cpf1 genome editing tool 

J. van der Oost (Inventor), P. van Baarlen (Inventor), Rogier Louwen (Inventor)

Research output: Patent


The invention relates to a Cpf1-based nuclease complex, wherein the guide RNA sequence is irreversibly crosslinked to the Cpf1 protein. The cross-link may be a covalent binding or a non-covalent binding. Such a complex may be used in delivering constructs to a cell that are capable of gene-editing. Use of this cross-linked complex will result in less off-targeting.
Original languageEnglish
Patent numberWO2017155407
Priority date11/03/16
Publication statusPublished - 14 Sep 2017


Dive into the research topics of 'Improved CRISPR-Cpf1 genome editing tool '. Together they form a unique fingerprint.

Cite this